TNFAIP3 and inflammatory bowel disease: Deletion of A20 in DC leads to the development of pathologies in mice similar to those seen in humans with inflammatory bowel disease (IBD) and SLE, including autoantibodies, splenomegaly, nephritis, colitis, and even ankylosing spondylitis (79–81).